BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kapoor S. Lubiprostone: Clinical applications beyond constipation. World J Gastroenterol 2009; 15(9): 1147-1147 [PMID: 19266613 DOI: 10.3748/wjg.15.1147]
URL: https://www.wjgnet.com/1007-9327/full/v15/i9/1147.htm
Number Citing Articles
1
Sherman M Chamberlain, Satish SC Rao. Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndromeExpert Opinion on Drug Safety 2012; 11(5): 841 doi: 10.1517/14740338.2012.708732
2
Hans-Dieter Allescher, Wolfram Reeker. Die AnästhesiologieSpringer Reference Medizin 2019; : 2055 doi: 10.1007/978-3-662-54507-2_136
3
Sunitha Kanchi Kandadai, Mark V. Boswell. Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care2015; : 345 doi: 10.1007/978-1-4614-8948-1_21
4
Ron Schey, Satish S. C. Rao. Lubiprostone for the Treatment of Adults with Constipation and Irritable Bowel SyndromeDigestive Diseases and Sciences 2011; 56(6): 1619 doi: 10.1007/s10620-011-1702-2
5
Nicholas Wilson, Ron Schey. Lubiprostone in constipation: clinical evidence and place in therapyTherapeutic Advances in Chronic Disease 2015; 6(2): 40 doi: 10.1177/2040622314567678
6
Peng Li, Xue-Qian He, Jie Dong, Jing Du. A meta-analysis of randomized controlled trials of the addition of lubiprostone to bowel preparation before colonoscopyMedicine 2020; 99(8): e19208 doi: 10.1097/MD.0000000000019208
7
Hans-Dieter Allescher, Wolfram Reeker. Die Anästhesiologie2018; : 1 doi: 10.1007/978-3-662-45539-5_136-1